A Director at Advaxis (NASDAQ: ADXS) is Buying Shares

By Carrie Williams

Today, a Director at Advaxis (NASDAQ: ADXS), Roni Appel, bought shares of ADXS for $40K.

This recent transaction increases Roni Appel’s holding in the company by 26.92% to a total of $128.4K.

See today’s analyst top recommended stocks >>

Currently, Advaxis has an average volume of 1.55M.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins.